Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)

Overview of attention for article published in Journal of Affective Disorders, February 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Readers on

mendeley: 66 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 625 followers.

RCT data: There were no differences between ketamine (0.5–0.9 mg/kg) and midazolam in cognitive outcomes according to 2 different cohorts with different dosing regimes in the short-term in people with TRD https://t.co/52XtRJhT5O

Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS). https://t.co/xP1HLVCg8y

Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS) https://t.co/kQ3gtdABFy

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.